BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Friday, April 3, 2020 1 min read

Key Takeaway: BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)